Meredith L. Leong

2.9k total citations · 1 hit paper
28 papers, 2.0k citations indexed

About

Meredith L. Leong is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Meredith L. Leong has authored 28 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 11 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Meredith L. Leong's work include interferon and immune responses (8 papers), Immunotherapy and Immune Responses (8 papers) and Listeria monocytogenes in Food Safety (5 papers). Meredith L. Leong is often cited by papers focused on interferon and immune responses (8 papers), Immunotherapy and Immune Responses (8 papers) and Listeria monocytogenes in Food Safety (5 papers). Meredith L. Leong collaborates with scholars based in United States, Switzerland and Japan. Meredith L. Leong's co-authors include Thomas W. Dubensky, Gary L. Firestone, David B. Kanne, Anita C. Maiyar, Weiqun Liu, Daniel A. Portnoy, Brian Kim, Edward E. Lemmens, Peter Lauer and Dirk G. Brockstedt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Meredith L. Leong

27 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

2015 581 citations Juan Fu, David B. Kanne et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meredith L. Leong United States	16	1.1k	907	443	326	326	28	2.0k
Eva Sapi United States	27	675 0.6×	806 0.9×	547 1.2×	55 0.2×	250 0.8×	58	2.2k
Maria Foti Italy	23	1.1k 1.0×	600 0.7×	237 0.5×	37 0.1×	335 1.0×	48	2.1k
Andreas Lengeling Germany	23	375 0.3×	1.2k 1.3×	92 0.2×	153 0.5×	183 0.6×	40	2.1k
Diane D. Eardley United States	23	1.5k 1.3×	448 0.5×	170 0.4×	54 0.2×	112 0.3×	46	2.1k
Anetta Härtlová Sweden	19	787 0.7×	1.1k 1.2×	291 0.7×	35 0.1×	246 0.8×	36	2.0k
Kristian Sass Bak‐Jensen Denmark	13	1.4k 1.2×	421 0.5×	303 0.7×	179 0.5×	66 0.2×	19	2.2k
Antoine Ménoret United States	26	1.4k 1.3×	1.6k 1.8×	297 0.7×	57 0.2×	178 0.5×	68	2.6k
Takashi Kanaya Japan	22	492 0.4×	691 0.8×	153 0.3×	37 0.1×	133 0.4×	38	1.5k
Carl W. Pierce United States	35	2.8k 2.5×	826 0.9×	274 0.6×	99 0.3×	93 0.3×	95	3.6k
Leon Eidels United States	22	865 0.8×	720 0.8×	130 0.3×	478 1.5×	211 0.6×	44	1.6k

Countries citing papers authored by Meredith L. Leong

Since Specialization

Citations

This map shows the geographic impact of Meredith L. Leong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith L. Leong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith L. Leong more than expected).

Fields of papers citing papers by Meredith L. Leong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith L. Leong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith L. Leong. The network helps show where Meredith L. Leong may publish in the future.

Co-authorship network of co-authors of Meredith L. Leong

This figure shows the co-authorship network connecting the top 25 collaborators of Meredith L. Leong. A scholar is included among the top collaborators of Meredith L. Leong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith L. Leong. Meredith L. Leong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lal, Shruti, Adrienne Sallets, Srinivasa Rao Bandi, et al.. (2025). Nanoparticle-formulated mRNA encoding engineered multivalent SIRPα-Fc fusion proteins shows robust anti-cancer activity in preclinical models. Molecular Therapy — Nucleic Acids. 36(2). 102550–102550.

Webster, Elizabeth R., Nicole E. Peck, Shima Gholizadeh, et al.. (2024). Discovery of a Peptoid-Based Nanoparticle Platform for Therapeutic mRNA Delivery via Diverse Library Clustering and Structural Parametrization. ACS Nano. 18(33). 22181–22193. 8 indexed citations

Sallets, Adrienne, Weiqun Liu, Shruti Lal, et al.. (2024). Development of NTX-472, a formulated mRNA therapy targeting CD20, CD19, and CD47, for treatment of B-cell lymphoma.. Journal of Clinical Oncology. 42(16_suppl). 2537–2537. 1 indexed citations

Deng, Weiwen, Anthony L. Desbien, Gabrielle L. Reiner, et al.. (2020). Abstract PR09: ADU-S100 (MIW815) synergizes with checkpoint blockade to elicit an antitumor CD8+ T-cell response to control distal tumors. Cancer Immunology Research. 8(4_Supplement). PR09–PR09. 4 indexed citations

Lemmens, Edward E., Weiqun Liu, Justin Skoble, et al.. (2019). A Potent and Effective SuicidalListeriaVaccine Platform. Infection and Immunity. 87(8). 12 indexed citations

Francica, Brian J., Ali Ghasemzadeh, Anthony L. Desbien, et al.. (2018). TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors. Cancer Immunology Research. 6(4). 422–433. 67 indexed citations

Dis, Erik Van, Kimberly M. Sogi, Chris S. Rae, et al.. (2018). STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection. Cell Reports. 23(5). 1435–1447. 91 indexed citations

Deng, Weiwen, Thomas E. Hudson, Edward E. Lemmens, et al.. (2018). Recombinant Listeria promotes tumor rejection by CD8 ⁺ T cell-dependent remodeling of the tumor microenvironment. Proceedings of the National Academy of Sciences. 115(32). 8179–8184. 70 indexed citations

Lee, Ji‐Sook, Meredith L. Leong, Yujun Huang, et al.. (2017). Abstract LB-198: Combination of PEGylated recombinant hyaluronidase PH20 (PEGPH20) with live-attenuated, double-deleted (LADD) Listeria enhances tumor infiltrating CD8+ T cell response and antitumor efficacy in mice. Cancer Research. 77(13_Supplement). LB–198. 2 indexed citations

10.

Leong, Meredith L., David B. Kanne, Laura Hix Glickman, et al.. (2013). Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). O20–O20. 1 indexed citations

11.

Dubensky, Thomas W., David B. Kanne, & Meredith L. Leong. (2013). Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants. PubMed. 1(4). 131–143. 151 indexed citations

12.

Leong, Meredith L., Johannes Hampl, Weiqun Liu, et al.. (2009). Impact of Preexisting Vector-Specific Immunity on Vaccine Potency: Characterization ofListeria monocytogenes-Specific Humoral and Cellular Immunity in Humans and Modeling Studies Using Recombinant Vaccines in Mice. Infection and Immunity. 77(9). 3958–3968. 42 indexed citations

13.

Škoberne, Mojca, Alice Yewdall, Keith S. Bahjat, et al.. (2008). KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. Journal of Clinical Investigation. 118(12). 3990–4001. 35 indexed citations

14.

Bahjat, Keith S., Rodney A. Prell, Heather E. Allen, et al.. (2007). Activation of Immature Hepatic NK Cells As Immunotherapy for Liver Metastatic Disease. The Journal of Immunology. 179(11). 7376–7384. 21 indexed citations

15.

Brockstedt, Dirk G., Meredith L. Leong, Keith S. Bahjat, et al.. (2007). Live-attenuated L. monocytogenes encoding mesothelin for immunotherapy of patients with pancreas and ovarian cancers. 67. 1874–1874. 3 indexed citations

16.

Buse, Patricia, et al.. (2007). The stimulus-dependent co-localization of serum- and glucocorticoid-regulated protein kinase (Sgk) and Erk/MAPK in mammary tumor cells involves the mutual interaction with the importin-alpha nuclear import protein. Experimental Cell Research. 313(15). 3261–3275. 7 indexed citations

17.

Yoshimura, Kiyoshi, Ajay Jain, Heather E. Allen, et al.. (2006). Selective Targeting of Antitumor Immune Responses with Engineered Live-Attenuated Listeria monocytogenes. Cancer Research. 66(2). 1096–1104. 48 indexed citations

18.

Maiyar, Anita C., Meredith L. Leong, & Gary L. Firestone. (2003). Importin-α Mediates the Regulated Nuclear Targeting of Serum- and Glucocorticoid-inducible Protein Kinase (Sgk) by Recognition of a Nuclear Localization Signal in the Kinase Central Domain. Molecular Biology of the Cell. 14(3). 1221–1239. 45 indexed citations

19.

Leong, Meredith L., Anita C. Maiyar, Brian Kim, Bridget O’Keeffe, & Gary L. Firestone. (2003). Expression of the Serum- and Glucocorticoid-inducible Protein Kinase, Sgk, Is a Cell Survival Response to Multiple Types of Environmental Stress Stimuli in Mammary Epithelial Cells. Journal of Biological Chemistry. 278(8). 5871–5882. 213 indexed citations

20.

Leong, Meredith L., et al.. (2000). Hyperosmotic Stress Stimulates Promoter Activity and Regulates Cellular Utilization of the Serum- and Glucocorticoid-inducible Protein Kinase (Sgk) by a p38 MAPK-dependent Pathway. Journal of Biological Chemistry. 275(33). 25262–25272. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact